Cheryl Maley
Seminars
Thursday 23rd July 2026
Roundtable Discussion: Exploring Future Opportunities for Radioligand Therapy Moiety Engineering to Optimize Therapeutic Activity
1:30 pm
- What moiety features most strongly drive tumor selectivity and residence time?
- How can radionuclide–moiety pairing be tuned to match tumor biology and dosimetry goals?
- How can imaging and modeling data be used to guide moiety optimization?
Wednesday 22nd July 2026
Optimizing your Drug from Discovery Phase: Key Targeting Moiety Engineering for Optimal Biodistribution & Half-life Whilst Minimizing Toxicity
Thursday 23rd July 2026
Beyond “Me-Too” Therapies: Prioritizing Targets Beyond PSMA for Meaningful RLT & Indication Differentiation
